These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18466055)

  • 1. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for amyotrophic lateral sclerosis.
    Bowser R; Cudkowicz M; Kaddurah-Daouk R
    Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
    Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis--the tools of the trait.
    Lederer CW; Santama N
    Biotechnol J; 2007 May; 2(5):608-21. PubMed ID: 17345579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis.
    Jackson CE; Bryan WW
    Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.
    Krüger T; Lautenschläger J; Grosskreutz J; Rhode H
    Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of amyotrophic lateral sclerosis subsets].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S29-4S33. PubMed ID: 17128087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S81-4S90. PubMed ID: 17128093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).
    Brettschneider J; Lehmensiek V; Mogel H; Pfeifle M; Dorst J; Hendrich C; Ludolph AC; Tumani H
    Neurosci Lett; 2010 Jan; 468(1):23-7. PubMed ID: 19853641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amyotrophic lateral sclerosis: differential diagnosis and frontier forms].
    Magistris MR
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S67-4S80. PubMed ID: 17128092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetranor PGDM analyses for the amyotrophic lateral sclerosis: positive and simple diagnosis and evaluation of drug effect.
    Shinozawa T; Urade Y; Maruyama T; Watabe D
    Biochem Biophys Res Commun; 2011 Dec; 415(4):539-44. PubMed ID: 22027143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young-onset sporadic amyotrophic lateral sclerosis: a distinct nosological entity?
    Gouveia LO; de Carvalho M
    Amyotroph Lateral Scler; 2007 Dec; 8(6):323-7. PubMed ID: 17852021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classical and atypical clinical features in amyotrophic lateral sclerosis].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S17-4S24. PubMed ID: 17128085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypes in ALS--clinical features and pathology].
    Sasaki S
    Brain Nerve; 2007 Oct; 59(10):1013-21. PubMed ID: 17969341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis: an update.
    de Carvalho M; Swash M
    Curr Opin Neurol; 2011 Oct; 24(5):497-503. PubMed ID: 21725240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.